1, the program will not cover Wegovy or Saxenda for weight treatment, but they could be covered for other indications
Notably, this was achieved in a shorter timeframe than the tirzepatide results, and with the weight loss curve still trending downward at the study endpoint suggesting the maximum effect had not yet been reached
2024 DOI: 10.1038/s41421-024-00702-y PMID: 39019866 Read on PubMed European Journal of Clinical Pharmacology A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Kaur M, Misra S 2024 DOI: 10.1007/s00228-024-03646-0 PMID: 38367045 Read on PubMed Cardiology in Review The First Triple Agonist for Antiobesity: Retatrutide Tetelbaum L, Mullally JA, Frishman WH 2024 DOI: 10.1097/CRD.0000000000000793 PMID: 39724554 Read on PubMed NPJ Metabolic Health and Disease Incretin triple agonist retatrutide alleviates obesity-associated cancer progression Marathe SJ, Grey EW, Bohm MS, et al
Other serum biomarkers, such as FibroTest, FIBC3, ADAPT, and PRO-C3 are available in practice
But these peptides could really help those who want better muscle growth, fat loss plus improved sleep quality